Recalls and suspensions

Subscribe to TGA safety information
14 September 2021
Recall due to risk of bacterial contamination
2 August 2021
Recall - Possible presence of benzene
3 June 2021
Product Defect Alert - child-resistant caps may not function correctly

More safety information »

Safety information

Subscribe to TGA safety information
25 October 2021
The TGA is aware that, in Europe, atrioventricular blocks have been reported in patients receiving high doses of continuous intravenous infusion of octreotide and in patients receiving bolus octreotide intravenously.
21 October 2021
Information about the TGA's safety monitoring of COVID-19 vaccines.
14 October 2021
Information about the TGA's safety monitoring of COVID-19 vaccines.
14 October 2021
The TGA published an Actemra (tocilizumab) shortage - consumer information sheet produced by Pain Australia

More safety information »

News

Subscribe to TGA latest news and updates
27 October 2021
Section 19A database has been updated to include new approvals
27 October 2021
The TGA has provisionally approved a booster dose of the Pfizer Australia Pty Ltd COVID-19 vaccine, COMIRNATY, for individuals 18 years and older.
26 October 2021
A presentation on the role of a UDI Issuing Agency, including project update and Q&A
25 October 2021
The TGA is modernising this process to move from a standalone paper-based form to an online form

More news »